Mustang Bio commences trading on the NASDAQ Global Market
Mustang Bio, a Fortress Company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell technology, announced that its common stock will commence trading on the NASDAQ Global Market under the symbol "MBIO." August 22, 2017